Delivery Order SPE2DR25D7068-SPE2DR26F5CB8
- Not listed
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a $1,827.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 56 tablets of Varenicline 1 mg on September 24, 2025, with completion expected by September 25, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The company, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $1,720.86 under firm fixed price terms. The award, issued on December 12, 2025, with an ultimate completion date of December 15, 2025, represents a non-competitive delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $3,018.61 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets in a 56-count package. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract, valued at $1,806.76, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,163.31 firm fixed-price delivery order is for the supply of 56 tablets of the medication Varenicline 1 mg. The contract has an ultimate completion date of March 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,393.34, is a Firm Fixed Price Delivery Order for the supply of Varenicline 1 mg tablets. The contract has an ultimate completion date of November 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract has a firm fixed-price of $3,593.93 and a completion date of October 11, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 56 tablets of the drug Varenicline 1 mg. The contract has a potential value of $4,815.66 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $2,117.08 and covers the delivery of Varenicline 1 mg tablets. It is a firm-fixed price contract that will run until November 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5CB8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,114.45 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets (56-count packages) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's longstanding pharmaceutical supply relationship with the federal government, specifically supporting military and veteran healthcare systems through DLA's medical supply chain. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves multiple federal healthcare entities including the Defense Health Agency and U.S. Coast Guard, supplying a comprehensive range of medications, vaccines, and medical supplies across diverse therapeutic areas. The company's demonstrated capability to fulfill federal procurement requirements through open competition, combined with its substantial IDC vehicle, positions it as a prime vendor for pharmaceutical support across military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/18/25 |